Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsGraft vs Host DiseaseBlood BanksHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Bone Marrow TransplantationTissue DonorsGraft SurvivalMelphalanGranulocyte Colony-Stimulating FactorTransplantation ChimeraLeukapheresisCombined Modality TherapyTreatment OutcomeCell DifferentiationBusulfanMyeloablative AgonistsMultiple MyelomaCyclophosphamideRecurrenceBlood Component RemovalHistocompatibility TestingMice, SCIDLiver TransplantationAntineoplastic Combined Chemotherapy ProtocolsRemission InductionHistocompatibilityWhole-Body IrradiationCells, CulturedImmunosuppressive AgentsLeukemiaRetrospective StudiesLymphoma, Non-HodgkinMesenchymal Stem Cell TransplantationAntineoplastic Agents, AlkylatingVidarabineDisease-Free SurvivalCell TransplantationHematopoiesisGraft vs Leukemia EffectBlood DonorsEtoposideInfectionTime FactorsTransplantation, IsogeneicSurvival RateThiotepaKidney TransplantationSurvival AnalysisSalvage TherapyEmbryonic Stem CellsHematologic DiseasesLeukemia, Myeloid, AcutePOEMS SyndromeAmyloidosisBlood CellsSpinal CordHodgkin DiseaseHLA AntigensMyelodysplastic SyndromesAdult Stem CellsCytarabineAnemia, AplasticVincristineTransplantation ImmunologyCytomegalovirus InfectionsFollow-Up StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred NODLiving DonorsLymphocyte DepletionFatal OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaCarmustineLymphomaImmunosuppressionHeart TransplantationChimerismPlatelet CountIfosfamideBone Marrow CellsCyclosporinePluripotent Stem CellsLymphocyte TransfusionGraft RejectionGraft vs Tumor EffectBone MarrowImmunophenotyping